Found: 22
Select item for more details and to access through your institution.
Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2276, doi. 10.1111/dom.14150
- By:
- Publication type:
- Article
Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 574, doi. 10.1111/dom.13931
- By:
- Publication type:
- Article
Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1474, doi. 10.1111/dom.13681
- By:
- Publication type:
- Article
Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 1027, doi. 10.1111/dom.13631
- By:
- Publication type:
- Article
Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1111, doi. 10.1111/dom.13194
- By:
- Publication type:
- Article
Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo‐controlled randomized study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 530, doi. 10.1111/dom.13116
- By:
- Publication type:
- Article
Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 520, doi. 10.1111/dom.13103
- By:
- Publication type:
- Article
Determining times to maximum urine excretion of 1-aminopyrene after diesel exhaust exposure.
- Published in:
- Journal of Exposure Science & Environmental Epidemiology, 2010, v. 20, n. 7, p. 650, doi. 10.1038/jes.2010.29
- By:
- Publication type:
- Article
Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease Two Randomized Clinical Trials and Lessons Learned.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 12, p. 1491, doi. 10.1001/jamaneurol.2015.2268
- By:
- Publication type:
- Article
Efficacy of ertugliflozin in monotherapy or combination therapy in patients with type 2 diabetes: A pooled analysis of placebo-controlled studies.
- Published in:
- Diabetes & Vascular Disease Research, 2019, v. 16, n. 5, p. 415, doi. 10.1177/1479164119842513
- By:
- Publication type:
- Article
Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: results from open-label extension.
- Published in:
- Rheumatology, 2022, v. 61, n. 2, p. 617, doi. 10.1093/rheumatology/keab346
- By:
- Publication type:
- Article
Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.
- Published in:
- Rheumatology, 2016, v. 55, n. 11, p. 1946, doi. 10.1093/rheumatology/kew230
- By:
- Publication type:
- Article
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
- Published in:
- Rheumatology, 2016, v. 55, n. 8, p. 1466, doi. 10.1093/rheumatology/kew179
- By:
- Publication type:
- Article
Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1175, doi. 10.1007/s13300-021-01018-w
- By:
- Publication type:
- Article
Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 6, p. 1347, doi. 10.1007/s13300-020-00803-3
- By:
- Publication type:
- Article
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 1, p. 253, doi. 10.1007/s13300-017-0358-0
- By:
- Publication type:
- Article
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 1, p. 193, doi. 10.1007/s13300-017-0354-4
- By:
- Publication type:
- Article
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 1, p. 49, doi. 10.1007/s13300-017-0337-5
- By:
- Publication type:
- Article
Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional Therapy.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 9, p. 1148, doi. 10.1093/ecco-jcc/jjz048
- By:
- Publication type:
- Article
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn’s Disease Treated With Infliximab [Remicade<sup>®</sup>] or Conventional Therapy.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 6, p. 680, doi. 10.1093/ecco-jcc/jjw221
- By:
- Publication type:
- Article
Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 6, p. 817, doi. 10.1002/mds.25395
- By:
- Publication type:
- Article
2353-PUB: Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2353-PUB
- By:
- Publication type:
- Article